The most common are gastrointestinal: nausea, vomiting, diarrhea, constipation, bloating, and reduced appetite
[1] Wegovy follows a more gradual escalation schedule over 1620 weeks: Weeks 14 : 0.25 mg once weekly Weeks 58 : 0.5 mg once weekly Weeks 912 : 1 mg once weekly Weeks 1316 : 1.7 mg once weekly Week 17 onward : 2.4 mg once weekly (maintenance dose) If patients do not tolerate a dose during titration, the prescribing information allows for delaying dose escalation for additional weeks
Novo Nordisk is conducting ongoing trials to explore the link between semaglutide use and diabetic retinopathy, with results expected by 2027
But like any eating pattern, its important to pay close attention to nutritionespecially when taking weight loss medications, which can suppress appetite and potentially increase the risk of nutrient deficiencies
And if you are curious about why doctors refer to good and bad cholesterol, read this
Who typically receives the 2mg/mL concentration This concentration appears frequently in early prescriptions and lower-dose maintenance protocols